Inappropriate prescribing of proton pump inhibitors in primary care

被引：157

作者：

Batuwitage, Bisanth Thushila ^{[1
]}

Kingham, Jeremy G. C. ^{[1
]}

Morgan, Nia Emma ^{[1
]}

Bartlett, Ruth Louise ^{[1
]}

机构：

[1] Singleton Hosp, Dept Med, Swansea SA2 8QA, W Glam, Wales

来源：

POSTGRADUATE MEDICAL JOURNAL | 2007年 / 83卷 / 975期

关键词：

D O I：

10.1136/pgmj.2006.051151

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Objectives: To determine if an educational intervention initiated in secondary care can influence prescribing of proton pump inhibitors (PPIs) in the community. Methods: A prospective study of PPI use in patients admitted to medical wards in a university hospital. A simple educational intervention was employed to reduce inappropriate prescribing of PPIs in the community. Results: In the pre-intervention analysis 66/271 (24%) patients were receiving treatment with a PPI prescribed in the community. In 36/66 (54%) patients the PPI had been prescribed inappropriately. Six months after the intervention 91/344 (26%) patients were prescribed a PPI in the community. In only 45 of these 91 (49%) patients was there a recommended indication. Conclusion: The intervention used in this study had no effect on the proportion of patients taking a PPI at the time of hospital admission or on the appropriateness of prescribing in the community.

引用

页码：66 / 68

页数：3

共 23 条

[1] Quality improvement report - Improving surveillance for Barrett's oesophagus [J].

Bampton, Peter A. ;

Schloithe, Anne ;

Bull, Jeff ;

Fraser, Robert J. ;

Padbury, Rob T. A. ;

Watson, David I. .

BMJ-BRITISH MEDICAL JOURNAL, 2006, 332 (7553) :1320-1323

[2]

Banait G, 2003, BRIT J GEN PRACT, V53, P94

[3]

*BNF, 2005, 51 BNF, P48

[4] Effect of implementation of a dyspepsia and Helicobacter pylori eradication guideline in primary care [J].

Cardin, F ;

Zorzi, M ;

Bovo, E ;

Guerra, C ;

Bandini, F ;

Polito, D ;

Bano, F ;

Grion, AM ;

Toffanin, R .

DIGESTION, 2005, 72 (01) :1-7

[5] Proton pump inhibitors as a risk factor for Clostridium difficile diarrhoea [J].

Cunningham, R ;

Dale, B ;

Undy, B ;

Gaunt, N .

JOURNAL OF HOSPITAL INFECTION, 2003, 54 (03) :243-245

[6] Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease [J].

Dial, S ;

Delaney, JAC ;

Barkun, AN ;

Suissa, S .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (23) :2989-2995

[7] Proton pump inhibitors and their drug interactions: an evidence-based approach [J].

Gerson, LB ;

Triadafilopoulos, G .

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2001, 13 (05) :611-616

[8]

Grime J, 2001, BRIT J GEN PRACT, V51, P703

[9]

Laheij RJ, 2004, JAMA-J AM MED ASSOC, V292, P2012

[10] Gastric acid-suppressive therapy and community-acquired respiratory infections [J].

Laheij, RJF ;

Van Ijzendoorn, MC ;

Janssen, MJR ;

Jansen, JBMJ .

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 18 (08) :847-851

← 1 2 3 →